Financial Snapshot

Revenue
$189.7M
TTM
Gross Margin
73.43%
TTM
Net Earnings
-$28.44M
TTM
Current Assets
Q3 2024
Current Liabilities
Q3 2024
Current Ratio
717.15%
Q3 2024
Total Assets
Q3 2024
Total Liabilities
Q3 2024
Book Value
$370.9M
Q3 2024
Cash
Q3 2024
P/E
-20.76
Nov 29, 2024 EST
Free Cash Flow
-$51.07M
TTM

Revenues

Revenues

Loading...

Revenue YoY Change

Loading...

Revenues

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014
Revenue $148.7M $122.3M $98.05M $71.08M $72.55M $57.56M $45.62M $37.30M $31.00M $23.68M
YoY Change 21.62% 24.72% 37.95% -2.03% 26.05% 26.17% 22.31% 20.3% 30.93%

Expenses

Cost Of Revenues

Loading...

Gross Profit

Loading...

Gross Profit Margin

Loading...

Gross Profit

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014
Revenue $148.7M $122.3M $98.05M $71.08M $72.55M $57.56M $45.62M $37.30M $31.00M $23.68M
Cost Of Revenue $37.48M $31.63M $24.65M $16.05M $17.93M $14.88M $11.17M $10.93M $9.367M $7.090M
Gross Profit $111.3M $90.66M $73.40M $55.03M $54.62M $42.68M $34.45M $26.37M $21.64M $16.60M
Gross Profit Margin 74.8% 74.14% 74.86% 77.42% 75.28% 74.15% 75.52% 70.69% 69.79% 70.1%

Selling, General & Admin Expense

Loading...

Research & Development

Loading...

Depreciation, Depletion & Amortization

Loading...

SGA Expense to Gross Profit Ratio

Loading...

R&D To Gross Profit Ratio

Loading...

DDA To Gross Profit Ratio

Loading...

Operating Expenses Total

Loading...

Operating Profits/Loss

Loading...

Operational Expenses

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014
Selling, General & Admin $126.8M $104.4M $85.73M $70.17M $57.95M $47.50M $37.50M $28.29M $26.44M $22.06M
YoY Change 21.44% 21.81% 22.18% 21.09% 21.99% 26.67% 32.54% 7.0% 19.85%
% of Gross Profit 114.0% 115.2% 116.8% 127.51% 106.09% 111.3% 108.85% 107.3% 122.2% 132.89%
Research & Development $10.20M $8.014M $5.543M $5.273M $5.748M $4.732M $3.423M $2.223M $1.789M $1.680M
YoY Change 27.23% 44.58% 5.12% -8.26% 21.47% 38.24% 53.98% 24.26% 6.49%
% of Gross Profit 9.16% 8.84% 7.55% 9.58% 10.52% 11.09% 9.94% 8.43% 8.27% 10.12%
Depreciation & Amortization $17.39M $13.10M $10.68M $8.010M $4.671M $2.892M $2.405M $1.902M $1.854M $1.580M
YoY Change 32.72% 22.65% 33.33% 71.48% 61.51% 20.25% 26.45% 2.59% 17.34%
% of Gross Profit 15.63% 14.45% 14.55% 14.56% 8.55% 6.78% 6.98% 7.21% 8.57% 9.52%
Operating Expenses $138.0M $116.1M $91.43M $81.79M $63.70M $52.23M $40.92M $32.49M $28.23M $23.74M
YoY Change 18.91% 26.94% 11.79% 28.4% 21.95% 27.64% 25.94% 15.11% 18.91%
Operating Profit -$26.75M -$25.40M -$18.02M -$26.76M -$9.077M -$9.553M -$6.472M -$6.127M -$6.592M -$7.140M
YoY Change 5.32% 40.92% -32.63% 194.76% -4.98% 47.61% 5.63% -7.05% -7.68%

Interest Expenses

Loading...

Interest Expenses To Operating Income %

Loading...

Other Expense/Income

Loading...

Interest & Other Expense/Income

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014
Interest Expense $3.178M $23.51M -$447.0K $3.412M $3.538M $2.255M $2.490M $1.476M $1.230M -$2.550M
YoY Change -86.48% -5358.61% -113.1% -3.56% 56.9% -9.44% 68.7% 20.0% -148.24%
% of Operating Profit
Other Income/Expense, Net $5.439M $21.71M $636.0K -$6.912M -$3.608M -$2.472M -$2.460M -$445.0K -$1.261M -$70.00K
YoY Change -74.95% 3313.52% -109.2% 91.57% 45.95% 0.49% 452.81% -64.71% 1701.43%

Income/Loss

Pretax Income

Loading...

Income Tax

Loading...

Net Profits/Loss

Loading...

Pretax Income YoY Change

Loading...

Income Tax Rate

Loading...

Net Profits/Loss YoY Change

Loading...

Basic EPS

Loading...

Net Income To Revenue Ratio

Loading...

Pretax & Net Income

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014
Pretax Income -$21.31M -$3.689M -$17.39M -$33.67M -$12.69M -$11.77M -$8.803M -$6.570M -$7.850M -$9.760M
YoY Change 477.72% -78.78% -48.35% 165.41% 7.79% 33.68% 33.99% -16.31% -19.57%
Income Tax -$338.0K -$4.947M -$1.128M -$723.0K $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
% Of Pretax Income
Net Earnings -$20.97M $1.258M -$16.26M -$32.94M -$13.73M -$12.03M -$8.932M -$6.572M -$7.891M -$9.550M
YoY Change -1767.25% -107.74% -50.64% 139.92% 14.19% 34.63% 35.91% -16.72% -17.37%
Net Earnings / Revenue -14.1% 1.03% -16.58% -46.35% -18.93% -20.89% -19.58% -17.62% -25.45% -40.33%
Basic Earnings Per Share -$0.92 $0.06 -$0.84 -$1.82 -$0.94
Diluted Earnings Per Share -$0.92 $0.06 -$0.84 -$1.82 -$0.94 -$957.0K -$699.3K -$545.7K -$655.3K -$793.2K

Assets & Liabilities

Cash & Short-Term Investments

Loading...

Cash & Equivalents

Loading...

Cash To Operating Expenses Ratio

Loading...

Inventory

Loading...

Receivables

Loading...

Total Short-Term Assets

Loading...

Property, Plant And Equipment

Loading...

Long-Term Investments

Loading...

Total Long-Term Assets

Loading...

Total Assets

Loading...

Net Income To Total Assets Percentage

Loading...

Accounts Payable

Loading...

Short-Term Debt

Loading...

Long Term Debt Due

Loading...

Total Short-Term Liabilities

Loading...

Long-Term Debt

Loading...

Other Long-Term Liabilities

Loading...

Total Long-Term Liabilities

Loading...

Total Liabilities

Loading...

Short-Term To Long-Term Debt Ratio

Loading...

Short-Term Assets To Debt Ratio

Loading...

Long-Term Debt To Net Income Ratio

Loading...

Assets & Liabilities

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014
Cash & Short-Term Investments $80.31M $118.3M $53.54M $83.90M $70.80M $60.70M $42.60M $1.600M $3.900M $6.600M
YoY Change -32.11% 120.93% -36.18% 18.5% 16.64% 42.49% 2562.5% -58.97% -40.91%
Cash & Equivalents $49.25M $109.3M $45.90M $55.10M
Short-Term Investments
Other Short-Term Assets $5.722M $5.437M $4.594M $4.000M $2.800M $1.300M $800.0K $200.0K $200.0K $900.0K
YoY Change 5.24% 18.35% 14.85% 42.86% 115.38% 62.5% 300.0% 0.0% -77.78%
Inventory $105.9M $78.19M $57.57M $53.00M $38.00M $25.70M $20.50M $14.90M $14.60M $17.30M
Prepaid Expenses
Receivables $34.62M $24.80M $17.94M $17.20M $16.00M $9.000M $5.600M $4.100M $3.800M $2.800M
Other Receivables $0.00 $0.00 $0.00 $300.0K $600.0K $500.0K $0.00 $0.00 $0.00 $0.00
Total Short-Term Assets $226.5M $226.7M $133.6M $158.4M $128.1M $97.20M $69.60M $20.80M $22.50M $27.50M
YoY Change -0.1% 69.64% -15.63% 23.65% 31.79% 39.66% 234.62% -7.56% -18.18%
Property, Plant & Equipment $41.05M $34.29M $28.52M $27.20M $21.30M $12.80M $10.40M $8.600M $7.300M $7.500M
YoY Change 19.72% 20.24% 4.83% 27.7% 66.41% 23.08% 20.93% 17.81% -2.67%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $2.940M
YoY Change
Total Long-Term Assets $212.2M $201.0M $170.6M $162.0M $54.10M $14.90M $12.70M $9.900M $8.200M $8.300M
YoY Change 5.59% 17.81% 5.32% 199.45% 263.09% 17.32% 28.28% 20.73% -1.2%
Total Assets $438.7M $427.7M $304.3M $320.4M $182.2M $112.1M $82.30M $30.70M $30.70M $35.80M
YoY Change
Accounts Payable $12.65M $11.15M $9.325M $10.00M $6.500M $4.000M $5.500M $3.500M $2.000M $600.0K
YoY Change 13.44% 19.57% -6.75% 53.85% 62.5% -27.27% 57.14% 75.0% 233.33%
Accrued Expenses $11.33M $6.744M $5.351M $10.90M $4.300M $3.600M $2.900M $2.200M $2.300M $1.500M
YoY Change 67.93% 26.03% -50.91% 153.49% 19.44% 24.14% 31.82% -4.35% 53.33%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $152.0K $144.0K $137.0K $100.0K $100.0K $100.0K $100.0K $100.0K $100.0K $100.0K
YoY Change 5.56% 5.11% 37.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%
Total Short-Term Liabilities $41.67M $30.87M $29.72M $35.00M $13.70M $9.200M $9.500M $7.300M $6.300M $3.200M
YoY Change 34.97% 3.89% -15.1% 155.47% 48.91% -3.16% 30.14% 15.87% 96.88%
Long-Term Debt $9.908M $763.0K $907.0K $1.000M $26.10M $21.20M $25.30M $17.40M $13.00M $14.60M
YoY Change 1198.56% -15.88% -9.3% -96.17% 23.11% -16.21% 45.4% 33.85% -10.96%
Other Long-Term Liabilities $4.663M $11.49M $43.51M $43.80M $100.0K
YoY Change -59.42% -73.59% -0.66% 43700.0%
Total Long-Term Liabilities $14.57M $12.25M $44.42M $44.80M $26.20M $21.20M $25.30M $17.40M $13.00M $14.60M
YoY Change 18.91% -72.41% -0.85% 70.99% 23.58% -16.21% 45.4% 33.85% -10.96%
Total Liabilities $61.72M $49.08M $78.91M $85.60M $39.80M $30.40M $34.80M $24.70M $19.40M $17.90M
YoY Change 25.76% -37.8% -7.82% 115.08% 30.92% -12.64% 40.89% 27.32% 8.38%

Ownership

Basic Shares Outstanding

Loading...

Diluted Shares Outstanding

Loading...

Preferred Stock

Loading...

Treasury Stock Shares

Loading...

Stock Issuance & Repurchase

Loading...

Ownership Data

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014
Basic Shares Outstanding 22.68M shares 20.70M shares 19.27M shares 18.06M shares 14.62M shares
Diluted Shares Outstanding 22.68M shares 20.95M shares 19.27M shares 18.06M shares 14.62M shares
Preferred Stock
Treasury Stock Shares

Return On Shareholders' Equity

Loading...

Book Value

Loading...

Free Cash Flow

Loading...

Free Cash Flow YoY

Loading...

Free Cash Flow Margin

Loading...

Dividends

Dividends

Loading...

Stock Price

Loading...
Market Cap: $590.63 Million

About ORTHOPEDIATRICS CORP

OrthoPediatrics Corp. is an orthopedic company, which engages in the design, development, and marketing of anatomically appropriate implants and devices for children with orthopedic conditions. The company is headquartered in Warsaw Indiana, Indiana and currently employs 247 full-time employees. The company went IPO on 2017-10-12. The firm is engaged in designing, developing, and marketing anatomically appropriate implants and devices for children with orthopedic conditions, giving pediatric orthopedic surgeons and caregivers. The firm sells its specialized products, including PediLoc, PediPlates, Cannulated Screws, PediFlex nail, PediNail, PediLoc Tibia, ACL Reconstruction System, Locking Cannulated Blade, Locking Proximal Femur, Spica Tables, RESPONSE Spine, BandLoc, Devise Rail, Orthex, The Fassier-Duval Telescopic Intramedullary System, SLIM Nail, The GAP Nail, The Free Gliding SCFE Screw System, GIRO Growth Modulation System, PNP Tibia System, ApiFix Mid-C System and Mitchell Ponset specialized bracing products to various hospitals and medical facilities throughout the United States and various international markets. The company markets 53 surgical and specialized bracing systems.

Industry: Surgical & Medical Instruments & Apparatus Peers: ATRION CORP AVANOS MEDICAL, INC. BIOLIFE SOLUTIONS INC CERUS CORP FIGS, Inc. MERIDIAN BIOSCIENCE INC Pulmonx Corp Silk Road Medical Inc UFP TECHNOLOGIES INC